This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland
BOOK NOW
Menu
BOOK NOW

Dr. Justin Killebrew, PhD
Vice President of Biology at Bonum Therapeutics
Speaker

Agenda Sessions

  • cLAG3-IL2 (BON-001): A Conditionally Active Therapeutic using Dual-Binding Antibody Technology

    , 16:45
    View Session

At this event

Prev
Next
Christian Klein, PhD
CXO in Residence & Drug Hunter
Curie.Bio

See Justin at Antibody Engineering & Therapeutics Europe

BOOK NOW